Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: A role for epigenetics?

Journal of Clinical Immunology

Volumn 31, Issue 5, 2011, Pages 773-777

  Buchbinder, David ^a   Nadeau, Kari ^b   Nugent, Diane ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

epigenetic; methylation; Primary immunodeficiency; thrombocytopenia

Indexed keywords

WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; AUTOIMMUNITY; CASE REPORT; CHILD; CPG ISLAND; DNA MODIFICATION; EFFECTOR CELL; EPIGENETICS; GENE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; MALE; MISSENSE MUTATION; MONOZYGOTIC TWINS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; THROMBOCYTOPENIA; WAS GENE; WISKOTT ALDRICH SYNDROME; X LINKED THROMBOCYTOPENIA;

ASYMPTOMATIC DISEASES; AUTOANTIBODIES; AUTOIMMUNITY; CELLS, CULTURED; CHILD; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; EPIGENESIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFANT, NEWBORN; INFECTION; MALE; MUTATION, MISSENSE; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES; THROMBOCYTOPENIA; TWINS, MONOZYGOTIC; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN; X-LINKED COMBINED IMMUNODEFICIENCY DISEASES;

EID: 80755153331     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9561-3     Document Type: Article

References (31)

1. LD Notarangelo 2010 Primary immunodeficiencies J Allergy Clin Immunol 125 S182 S194 20042228 10.1016/j.jaci.2009.07.053
2. MS Lim K Elenitoba-Johnson 2004 The molecular pathology of primary immunodeficiencies J Mol Diagn 6 59 83 15096561 10.1016/S1525-1578(10)60493-X 1:CAS:528:DC%2BD2cXksVSqtLs%3D (Pubitemid 38584544)
3. M Morange 2002 The relations between genetics and epigenetics: a historical point of view Ann N Y Acad Sci 981 50 60 12547673 10.1111/j.1749-6632.2002.tb04911.x 1:CAS:528:DC%2BD3sXht1eqsr4%3D (Pubitemid 36127085)
4. R Holiday 2006 Epigenetics: a historical overview Epigenetics 1 76 80 10.4161/epi.1.2.2762
5. RS Geha LD Notarangelo J-L Casanova, et al. 2007 Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee J Allergy Clin Immunol 120 776 794 17952897 10.1016/j.jaci.2007.08.053
6. RH Buckley 2005 Variable phenotypic expression of mutations in genes of the immune system J Clin Invest 115 2974 2976 16276411 10.1172/JCI26956 1:CAS:528:DC%2BD2MXhtF2kt7zL (Pubitemid 41567562)
7. F Meda M Folci A Baccarelli, et al. 2011 The epigenetics of autoimmunity Cell Mol Immunol 8 226 236 21278766 10.1038/cmi.2010.78 1:CAS:528: DC%2BC3MXlsVCms7k%3D
8. A Hewagama B Richardson 2009 The genetics and epigenetics of autoimmune disease J Autoimmun 33 3 11 19349147 10.1016/j.jaut.2009.03.007 1:CAS:528:DC%2BD1MXms1Wgur4%3D
9. M Erlich C Sanchez C Shao, et al. 2008 ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation Autoimmunity 41 253 271 10.1080/08916930802024202 (Pubitemid 351593856)
10. M Erlich 2003 The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease Clin Immunol 109 17 28 10.1016/S1521-6616(03)00201-8 (Pubitemid 37324738)
11. M Bosticardo F Marangoni A Aiuti, et al. 2009 Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome Blood 113 6288 6295 19351959 10.1182/blood-2008-12-115253 1:CAS:528:DC%2BD1MXnvFGnsrs%3D
12. HD Ochs AH Filipovich P Veys, et al. 2009 Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment Biol Blood Marrow Transplant 15 84 90 19147084 10.1016/j.bbmt.2008.10.007
13. MH Albert TC Bittner S Nonoyama, et al. 2010 X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options Blood 115 3231 3238 20173115 10.1182/blood-2009-09-239087 1:CAS:528:DC%2BC3cXlvVags7s%3D
14. V Gulacsy T Freiberger A Shcherbina, et al. 2011 Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome Mol Immunol 48 788 792 21185603 10.1016/j.molimm.2010.11.013 1:CAS:528:DC%2BC3MXovVartw%3D%3D
15. LJ Thompson M Lalloz DM Layton 1999 Unique and recurrent WAS gene mutation in Wiskott-Aldrich syndrome and X-linked thrombocytopenia Blood Cells Mol Dis 25 218 226 10575547 10.1006/bcmd.1999.0247 1:STN:280: DC%2BD3c%2Fkt1yjsw%3D%3D (Pubitemid 29521423)
16. Q Zhu C Watanabe T Liu, et al. 1997 Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype Blood 90 2680 2689 9326235 1:CAS:528:DyaK2sXmtlenurg%3D (Pubitemid 27413478)
17. Y Jin C Mazza JR Christie, et al. 2004 Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation Blood 104 4010 4019 15284122 10.1182/blood-2003- 05-1592 1:CAS:528:DC%2BD2cXhtFaju7jO (Pubitemid 39620151)
18. K Imai T Morio Y Zhu, et al. 2004 Clinical course of patients with WASP gene mutations Blood 103 456 464 12969986 10.1182/blood-2003-05-1480 1:CAS:528:DC%2BD2cXmsFequg%3D%3D (Pubitemid 38140073)
19. D Schindelhauer M Weiss H Hellebrand, et al. 1996 Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product Hum Genet 98 68 76 8682510 10.1007/s004390050162 1:CAS:528:DyaK28Xktlynu7c%3D (Pubitemid 26181285)
20. C Fillat T Espanol M Oset, et al. 2001 Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome Am J Med Genet 100 116 121 11298372 10.1002/ajmg.1228 1:STN:280:DC%2BD3M3gvFOitQ%3D%3D (Pubitemid 32285283)
21. GP Yu D Chiang SJ Song, et al. 2009 Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease Clin Immunol 131 240 253 19162554 10.1016/j.clim.2008.12.006 1:CAS:528:DC%2BD1MXksVWgtLY%3D
22. KC Nadeau A Callejas WB Wong, et al. 2008 Idiopathic neutropenia of childhood is associated with Fas/FasL expression Clin Immunol 129 438 447 18819843 10.1016/j.clim.2008.08.006 1:CAS:528:DC%2BD1cXhtlGhsbfF
23. KD Nguyen C Vanichsarn A Fohner, et al. 2009 Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma J Allergy Clin Immunol 123 933 939 19152963 10.1016/j.jaci.2008.11.037 1:CAS:528:DC%2BD1MXktV2itrs%3D
24. K Forsyth R Seshadri C Matthews R Heddle 1988 Wiskott-Aldrich in identical twins: abnormality of CD4 and CD8 positive lymphocytes Aust NZ J Med 18 73 76 10.1111/j.1445-5994.1988.tb02247.x 1:STN:280:DyaL1c3otVKqsQ%3D%3D
25. H Xie M Wang A de Andrade, et al. 2011 Genome-wide quantitative assessment of variation in DNA methylation patterns Nucleic Acids Res 39 4099 4108 21278160 10.1093/nar/gkr017 1:CAS:528:DC%2BC3MXmvValsrg%3D
26. T Ushijima N Watanabe E Okochi, et al. 2003 Fidelity of the methylation pattern and its variation in the genome Genome Res 13 868 874 12727906 10.1101/gr.969603 1:CAS:528:DC%2BD3sXjs1Oquro%3D (Pubitemid 36621747)
27. EL Pearce 2006 Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection Immunol Rev 211 197 202 16824128 10.1111/j.0105-2896.2006.00399.x 1:CAS:528:DC%2BD28Xot1Grsb4%3D (Pubitemid 43882972)
28. CE McCall B Yoza T Liu, et al. 2010 Gene-specific epigenetic regulation in serious infections with systemic inflammation J Innate Immun 2 395 405 20733328 10.1159/000314077
29. AB Csoka M Szyf 2009 Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology Med Hypotheses 73 770 780 19501473 10.1016/j.mehy.2008.10.039 1:CAS:528:DC%2BD1MXht1Gks73O
30. RA Copeland EJ Olhava MP Scott 2010 Targeting epigenetic enzymes for drug discovery Curr Opin Chem Biol 14 505 510 20621549 10.1016/j.cbpa.2010.06.174 1:CAS:528:DC%2BC3cXpvVyqtrs%3D
31. GS Mack 2006 Epigenetic cancer therapy makes headway JNCI 98 1443 1444 17047192